Segment Reporting - Schedule of Significant Expense (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Significant Expense [Abstract] | ||||||||
| Product revenue | $ 1,973,105 | $ 1,696,050 | $ 6,727,790 | $ 6,356,767 | ||||
| Cost of product revenue | 790,496 | 781,215 | 2,987,089 | 2,743,982 | ||||
| Product gross profit | 1,182,609 | 914,835 | 3,740,701 | 3,612,785 | ||||
| License revenue | 3,000,000 | |||||||
| Operating expenses: | ||||||||
| General and administrative | 1,693,450 | 1,264,808 | 4,651,242 | 4,501,069 | ||||
| Sales | 261,079 | 150,009 | 634,372 | 512,361 | ||||
| Marketing | 227,239 | 204,133 | 700,980 | 589,388 | ||||
| Development | 1,172,517 | 1,039,733 | 3,727,222 | 3,379,700 | ||||
| Quality assurance | 252,636 | 142,752 | 555,701 | 485,676 | ||||
| Total operating expenses | 3,606,921 | 2,801,435 | 10,269,517 | 9,468,194 | ||||
| Loss from operations | (2,424,312) | (1,886,600) | (6,528,816) | (2,855,409) | ||||
| Fair value change in warrant liability | 405,702 | 319,625 | 620,171 | 1,099,421 | ||||
| Financing costs | (9,325) | (334,063) | ||||||
| Other income | 12,279 | 75,432 | 82,402 | 103,898 | ||||
| Loss before income taxes | (2,006,331) | (1,500,868) | (5,826,243) | (1,986,153) | ||||
| Provision for income taxes | ||||||||
| Net loss | $ (2,006,331) | $ (2,382,022) | $ (1,437,890) | $ (1,500,868) | $ (2,270,607) | $ 1,785,322 | $ (5,826,243) | $ (1,986,153) |
| X | ||||||||||
- Definition The amount of collaboration revenues. No definition available.
|
| X | ||||||||||
- Definition Expenses associated with research and development excluding quality assurance activity costs. No definition available.
|
| X | ||||||||||
- Definition The amount represent issuance costs attributed to the warrant instruments classified as a liability and to costs attributed to the debt facility. No definition available.
|
| X | ||||||||||
- Definition Expenses associated with quality control activities. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|